EV1000 Clinical Platform recalled over fire hazard
- Recall date
- March 21, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Edwards Lifesciences, LLC recalls EV1000 Clinical Platform, Models: EV1000A, EV1000NI, EV1000CS Product Usage: EV1000A Monitor is used to optimize fluid…
- Recall number
- Z-1193-2019
- FDA classification
- Class I
- Brand / firm
- Edwards Lifesciences, LLC
- Sold / distributed
- Worldwide Distribution - US Nationwide : FL, MD, NY, TX, VA, CO, OK, MO, CA, DE, TN, NC, DC, PA, MA, OR, SC, OH, WI, KS, NV, MI, IL, KY, GA, NJ, WA, CT, IN, MN, WV, LA, MS, AL, SD, NE, IA, AZ, ID, HI, UT, ME,MT, NM, AK, NH, RI, AR, ND, WY, PR. Foreign (OUS): IT, FI, CO, KR, JP, PL, BE, GR, NL, IL,…
Why it was recalled
Potential for an electrical short circuit leading to possible fire hazard due to liquid ingress into AC power outlets.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
EV1000 Clinical Platform, Models: EV1000A, EV1000NI, EV1000CS Product Usage: EV1000A Monitor is used to optimize fluid management through the use of minimally invasive monitoring with the FloTrac sensor (or the Volume View sensor).
Get recall alerts
Free email alert whenever Edwards Lifesciences, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Edwards Lifesciences, LLC